Vitality Biopharma Inc (OTCMKTS:VBIO) shares passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.30 and traded as high as $0.20. Vitality Biopharma shares last traded at $0.12, with a volume of 12,106 shares changing hands.
The stock has a 50-day simple moving average of $0.19 and a 200-day simple moving average of $0.30. The company has a debt-to-equity ratio of 0.03, a current ratio of 4.08 and a quick ratio of 4.08.
Vitality Biopharma (OTCMKTS:VBIO) last announced its earnings results on Tuesday, August 13th. The company reported ($0.02) earnings per share (EPS) for the quarter. Vitality Biopharma had a negative net margin of 7,774.90% and a negative return on equity of 333.89%.
Vitality Biopharma, Inc engages in the development of cannabinoid pharmaceuticals for the treatment of neurological and inflammatory disorders in the United States. The company's products in pipeline include VBX-100, an oral cannabinoid formulation for inflammatory bowel disease, C.difficile-associated diarrhea and colitis, and narcotic bowel syndrome; and VBX-210, a cannabinoid formulation, which is in preclinical studies for the treatment of gastrointestinal conditions.
Further Reading: Equal Weight Rating
Receive News & Ratings for Vitality Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitality Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.